Оptoelectronic Technology: a Sufficient Alternative or a Necessary Aid in Cervical Cancer Screening?
https://doi.org/10.31550/1727-2378-2024-23-5-67-72
Abstract
Aim. To review the advantages and disadvantages of using an optoelectronic cervical screening method to detect cervical intraepithelial neoplasia and cervical cancer.
Key points. At the present stage, the use of optical-electronic scanning is extremely important for the best diagnosis of cervical precancerous lesions. It can help to reduce the incidence of cervical cancer and will benefit the health of women.
Conclusion. The optoelectronic technology provides sensitivity comparable to that of liquid cytologic examination of cervical micro specimens and can be used both as a primary screening method and for selection of HPV-positive patients for further diagnostic and therapeutic measures.
About the Author
A. I. Buinyakova
IMSystems
Russian Federation
Russian Federation
23 Novgorodskaya Str., Saint Petersburg, 191124
References
1. Kaprin A.D., Starinsky V.V., Shakhzadova A.O., eds. The state of oncologic assistance to the Russian population in 2023. M.: P.A. Herzen Moscow Research Institute of Oncology — a department of the Federal State Budgetary Institution NMRC of Radiology; 2024. 262 р. (in Russian)
2. Volchenko N.N., Borisova O.V. Errors in cervical cytological diagnostics. Russian News of Clinical Cytology. 2020;24(1):17–22. DOI: 10.24411/1562-4943-2020-10103
3. Artymuk N.V. Cervical screening. Doctor.Ru. 2021;20(1):56–60. (in Russian). DOI: 10.31550/1727-2378-2021-20-1-56-60
4. Shabalova I.P., Kasoyan K.T., eds. Liquid and conventional cytology in cervical diseases. A cytologic atlas. M.; 2016. 320 p. (in Russian)
5. Koliopoulos G., Nyaga V.N., Santesso N., Bryant A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 2017;8(8):CD008587. DOI: 10.1002/14651858.CD008587.pub2
6. Quek S.C., Mould T., Canfell K., Singer A. et al. The Polarprobe emerging technology for cervical cancer screening. Ann. Acad. Med. Singap. 1998;27(5):717–21.
7. Özdemir H., Şerbetçioğlu G.Ç., Ayhan A. New screening method for cervical cancer — Polar Probe. Dicle Med. J. 2020;47(3):587–95.
8. Suchońska B., Gajzlerska-Majewska W., Wielgoś M. Evaluation of a real-time optoelectronic method in the diagnostics of CIN over four years of observations PLoS One. 2021;16(2):e0247702. DOI: 10.1371/journal.pone.0247702
9. Yang H., Zhang X., Hao Z. The diagnostic accuracy of a real-time optoelectronic device in cervical cancer screening A PRISMA-compliant systematic review and meta-analysis. Medicine. 2018;97:e11439. DOI: 10.1097/MD.0000000000011439 PMID: 30024517
10. Lee S.J., Bae J.H., Kim J.H., Lee S.H. et al. A real-time optoelectronic device in screening of cervical intraepithelial neoplasia. J. Womens Med. 2009;2:23–8.
11. Chen F., Zhang G., Cui M., Zhang Y. et al. Evaluation of the effectiveness of an all powered optoelectronic technology in cancer screening. From TruScreen International Virtual Symposium with Australia, China, Zimbabwe, Saudi Arabia and the Russian Federation. 2023.
12. Vet J.N.I., Haindl J.P., Velasquez C., Parker L.J. et al. A performance evaluation of an optoelectronic cervical screening device in comparison to cytology and HPV DNA testing. Eur. J. Gynaecol. Oncol. 2022;43(2):213–18.
13. Yang X., He L., Xiao X., Yan L. et al. Effectiveness of TruScreen for detecting CIN II+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Future Oncol. 2023;19(37):2493–504. DOI: 10.2217/fon-2023-0297
14. Yang Y., Xu L., Yuan S., Lv J. et al. Optimal screening and detection strategies for cervical lesions: a retrospective study. J. Cancer. 2024;15(11):3612–24. DOI: 10.7150/jca.96128
15. Zarochentseva N.V., Belaya Yu.M. Cervical diseases in young women. Issues of practical colposcopy. Genital Infections. 2023;1:32–7. DOI: 10.46393/27826392_2023_1_32
16. Ma Y., Di J., Bi H., Zhao Q. et al. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: a real-world study based on population screening of cervical cancer in rural areas of China. PLoS One. 2020;15(7):e0233986. DOI: 10.1371/journal.pone.0233986
17. Wei Y., Wang W., Cheng M., Hong Z. et al. Clinical evaluation of a real-time optoelectronic device in cervical cancer screening. Eur. J. Obstet. Gynecol. Reprod. Biol. 2021;266:182–6. DOI: 10.1016/j.ejogrb.2021.09.027
Review
For citations:
Buinyakova A.I. Оptoelectronic Technology: a Sufficient Alternative or a Necessary Aid in Cervical Cancer Screening? Title. 2024;23(5):67-72. (In Russ.) https://doi.org/10.31550/1727-2378-2024-23-5-67-72
Views:
11
Email this article 